<?xml version='1.0' encoding='utf-8'?>
<section xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>48-831.05</num>
  <heading>Rebate agreement.</heading>
  <text>A drug manufacturer or labeler that sells prescription drugs in the District through any publicly funded pharmaceutical assistance program shall enter into a rebate agreement with the Department under AccessRx. The rebate agreement shall require the manufacturer or labeler to make rebate payments to the District for deposit in the AccessRx Fund each calendar quarter or according to a schedule established by the Department.</text>
  <annotations>
    <annotation doc="D.C. Law 15-164" type="History">May 18, 2004, D.C. Law 15-164, ยง 105, 51 DCR 3688</annotation>
    <annotation type="Section References">This section is referenced in ยง <cite path="ยง48-831.33">48-831.33</cite>.</annotation>
  </annotations>
</section>
